Edgewise Therapeutics Free Cash Flow (Quarterly) Analysis

Edgewise Therapeutics Inc (EWTX)

32.87 -0.39 (-1.17%) USD | NASDAQ | Nov 14, 16:00

32.87 0.00 (0.00%) After-Hours: 04:46

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
September 30, 2024	-27.89M
June 30, 2024	-26.32M
March 31, 2024	-28.90M
December 31, 2023	-26.99M
September 30, 2023	-22.52M
June 30, 2023	-20.99M
March 31, 2023	-27.19M
December 31, 2022	-15.15M
September 30, 2022	-13.29M
June 30, 2022	-16.80M

Date	Value
March 31, 2022	-12.94M
December 31, 2021	-9.498M
September 30, 2021	-8.713M
June 30, 2021	-9.845M
March 31, 2021	-6.119M
December 31, 2020	-4.638M
September 30, 2020	-3.278M
June 30, 2020	-4.173M
March 31, 2020	-2.748M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-28.90M

Minimum

Mar 2024

-2.748M

Maximum

Mar 2020

-15.16M

Average

-13.29M

Median

Sep 2022

Free Cash Flow (Quarterly) Benchmarks